首页> 美国卫生研究院文献>Food Science Nutrition >The effect of sorghum resistance resistant starch‐mediated equol on the histological morphology of the uterus and ovaries of postmenopausal rats
【2h】

The effect of sorghum resistance resistant starch‐mediated equol on the histological morphology of the uterus and ovaries of postmenopausal rats

机译:耐高粱抗性淀粉介导的equol对绝经后大鼠子宫和卵巢组织学形态的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Equol is a metabolite of daidzein and has a higher biological activity than daidzein. Equol, combined with estrogen receptors, can reduce the incidence of diseases such as cardiovascular disease, osteoporosis, and breast cancer; more effectively alleviate the symptoms of perimenopausal syndrome; and improve age‐related decline of the uterus and ovaries. Research has shown that food composition can greatly affect the formation of equol in the intestinal tract. In the intestines, the content of nonstarch polysaccharides that can stimulate fermentation is high, thereby allowing intestinal bacteria to quickly and completely transform the daidzein into equol. This study used Sprague Dawley ( ) rats as a model, where menopause was established through direct intragastric administration of formistan. In the 6‐week‐long experiment, intragastric administration of RS while feeding bean pulp reduced the body weight of postmenopausal rats, reduced the efficiency of feed utilization of rats, and increased the weight of organs such as the uterus and ovaries. Routine blood indexes showed that no adverse reactions were produced by intragastric administration of RS. 16s rDNA sequencing further verified and XIVa, as the bacteria that converted daidzein into equol.
机译:Equol是Daidzein的代谢物,具有比Daidzein的更高的生物活性。交牌,与雌激素受体相结合,可以减少心血管疾病,骨质疏松症和乳腺癌等疾病的发生率;更有效地减轻围囊综合征的症状;并改善子宫和卵巢的年龄相关衰退。研究表明,食品组合物可以极大地影响肠道中的equol的形成。在肠道中,可以刺激发酵的非淀粉多糖的含量高,从而允许肠道细菌快速并完全将Deafzein变为equol。本研究使用Sprague Dawley()大鼠作为模型,通过直接胃部施工来确定更年期。在6周的实验中,胃肠瘤的胃肠施用减少了绝经后大鼠的体重,降低了大鼠的饲料利用效率,并增加了子宫和卵巢等器官的重量。常规血液指标表明,通过胃内施用卢比没有产生不良反应。 16S RDNA测序进一步验证和XIVA,作为将Daidzeinin转化为Equol的细菌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号